A Penicillin Allergy Questionnaire for Outpatient Clinics
July 15th 2024Clinicians developed an algorithm and screening questionnaire for outpatient penicillin allergy evaluation, designed to stratify patients into high- and low-risk penicillin allergy groups. Here is the sample questionnaire to consider for use in clinics.
FluGen’s Intranasal Vaccine Shows Promise in Boosting Flu Protection for Older Adults
July 12th 2024Adults 65 and older account for 70–85% of annual influenza-related deaths in the USA, underscoring the need for improved vaccine options, as current injectable vaccines show modest efficacy in many seasons.
From Pathogen to Infectious Disease Diagnosis
July 12th 2024Here is our inaugural podcast with our host, Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc, who interviews guests on connecting lab professionals to clinicians and the intricacies of assays, the next generation of diagnostics, and the nuances of interpreting test results.
Exploring the Dual Benefits of COVID-19 Vaccination in Mitigating Asthma Symptoms in Children
Published: July 11th 2024 | Updated: July 11th 2024Matthew M Davis, MD, MAPP elaborates on how higher COVID-19 vaccination rates may curb the virus, alleviate childhood asthma symptoms, and protect against other common colds.
cUTI Roundtable: Discussing and Diagnosing These Difficult Infections
July 10th 2024This series looks to discuss several topics around these infections including diagnosis, treatment, challenges in managing UTIs in patients with dementia and neurogenic bladders, antibiotic resistance, and considerations for patients and caregiver engagement.
The CDC’s Rapid Detection Assays on Combating the Spread of Anopheles stephensi
July 10th 2024Christina Rafferty, BSc, an expert from the CDC, discusses the CLASS assay for swift and accurate detection of Anopheles stephensi, which is essential for controlling malaria spread and protecting communities from resurgence in Africa.
Advancing Viral Disease Treatment of Recurrent Genital Herpes, Hepatitis B and D Viruses
July 7th 2024The healthcare sector currently faces an unmet need in treating herpesviruses, hepatitis B, and hepatitis D, which could significantly improve patient outcomes. Addressing this involves considering the necessary steps and understanding the challenges pharmaceutical companies encounter as they work towards developing treatments for these conditions.
Immune Response Dynamics in Solid Organ Transplant Recipients After Omicron Booster Vaccinations
July 3rd 2024Boosted neutralization against variant XBB15 fades within 3 months post-first booster in transplant recipients but improves with a second, hybrid immunity enhances, suggesting 3-6 month boost intervals for solid organ transplant recipients.
Avian Influenza in Dairy Cattle: Implications for Milk Production and Biosecurity
July 2nd 2024Recent studies in Emerging Infectious Diseases have highlighted the persistence of highly pathogenic avian influenza A (H5N1) virus on milking equipment surfaces and its presence in dairy cattle mammary glands.